Erika Zecca

6PUBLICATIONS
34CO-AUTHORS
Intensive careFood properties (incl. characteristics and health benefits)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 04, 2026
Higher 25(OH)D Levels at Admission Predict a Favorable Disease Evolution in Moderate-to-Severe COVID-19 Patients.

|Mar 11, 2023
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial.

Erica Matino, Elena Tavella, Manuela Rizzi

|Oct 27, 2022
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients.

Manuela Rizzi, Stelvio Tonello, Francesca Morani

|Aug 26, 2022
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort.

Erika Zecca, Manuela Rizzi, Stelvio Tonello

|May 09, 2022
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients.

Stelvio Tonello, Manuela Rizzi, Erica Matino

|Mar 04, 2022
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein.

Manuela Rizzi, Martina Costanzo, Stelvio Tonello

Pageof 1

Frequent Collaborators

6 joint publications

Manuela Rizzi

6 joint publications

Pier Paolo Sainaghi

6 joint publications

Luigi Mario Castello

5 joint publications

Eleonora Rizzi